07/30/2026

Kano Therapeutics Financial Conflict of Interest (FCOI) Policy

Read More

Articles 12/12/2025

MIT News: A better DNA material for genetic medicine

Read More

Press Releases 10/29/2025

Kano selected as a recipient of the Massachusetts Manufacturing Innovation Initiative (M2I2) grant

Read More

Announcements 09/04/2025

Collaboration with Merck KGaA, Darmstadt, Germany

Read More

Announcements 09/03/2025

Kano accepted into the NVIDIA Inception program

Read More

Articles 07/01/2025

DNA templates and why cell and gene therapies will define future medicines

Read More